Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Guillermo Garcia-Manero, MD
M.D. Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Southern Cancer Center
Mobile, Alabama, United States
- City of Hope
Duarte, California, United States
- Usc Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Sutter Medical Group
Sacramento, California, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- Yale School of Medicine
New Haven, Connecticut, United States
- Florida Cancer Specialist South
Fort Myers, Florida, United States
- Florida Cancer Specialist North
St. Petersburg, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- University of Kansas Cancer Center
Westwood, Kansas, United States
- University of Kentucky
Lexington, Kentucky, United States
- John Theurer Cancer Center
Hackensak, New Jersey, United States
- Oncology Hematology Care
Cincinati, Ohio, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- University of Oklahoma Health Science Center
Oklahoma City, Oklahoma, United States
- Tennessee Oncology-Chattanooga
Chattanooga, Tennessee, United States
- Tennessee Oncology
Nashville, Tennessee, United States
- Baylor University Medical Center
Dallas, Texas, United States
- University of Texas Southwestern
Dallas, Texas, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Cancer Care Centers of South Texas
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2013
- Primary completion
- 31 May 2015
- Completion
- 30 Jun 2016
- Last update posted
- 23 Feb 2017
- Registered enrollment
- 45
- Registry id
- NCT01993641
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.